Word

RESEARCH PIECES

Status

Pending

Status Code

661

Status Date

Friday, May 3, 2024

Serial Number

79363770

Mark Type

3

Filing Date

Wednesday, November 30, 2022

Trademark Owner History

RESEARCH PIECES

Classifications

5 Biological, chemical, biochemical preparations, antibodies, antiviral, antibiotics, anticancer, substances, products, agents, molecules, reagents for medical and pharmaceutical use for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders, or cancer; chemical and biochemical products for pharmaceutical use for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; chemico-pharmaceutical products for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical products for the prevention and treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical products, agents or molecules targeting neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical products for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer for use in organ transplant; organotherapy preparations; chemical and biological reagents for medical use for analyses for medical use; reagents for in vitro use in laboratories for medical use; reagents for use in genetic testing and medical diagnostic testing; diagnostic chemical reagents for medical use; reagents for chemical and microbiological analyses for medical use; immunological reagents for medical use; biological preparations from tissues, organs, biochemical, biotechnological and chemical preparations for medical use for analyses and treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; chemical preparations for medical use for blood analysis of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; preparations of micro-organisms for medical use for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; chemical-pharmaceutical preparations for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical preparations for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical preparations and substances for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical preparations for tissue regeneration for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical preparations containing stem cells for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical preparations for human use for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical preparations for activating cellular function for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; diagnostic in vitro preparation for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; living cells for medical use; stem cells for medical use; stem cells for use in cell and gene therapies for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; pharmaceutical compositions containing stem cells for the treatment of neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; culture media for grafts or implants; bacteriological culture media and culture media for bacteriology for medical use; cell growth media for growing cells for medical use; cell culture media for grafts, implants; cultures for grafts, implants and stem cells; biological tissue cultures for medical use; cultures of micro-organisms for grafts, implants and stem cells in neurodegenerative, inflammatory, infectious and viral diseases, immune and metabolic disorders or cancer; blood for medical purposes; surgical implants comprised of living tissues obtained from stem cells; biological organs, grafts, implants tissues for implantation and transplantation; grafts in the nature of skin grafts, arterial grafts, and biotechnical tissue grafts; arterial grafts; vascular grafts in the nature of organs; skin grafts; biological implants and implants, namely cells culture, stem cells, tissues for pharmaceutical use; implants comprising living tissues for guided tissue regeneration; surgical implants comprised of living tissues, grown from stem cells; human tissue for allografts; processed human donor skin for the replacement of soft tissue and biological tissue culture for medical use; human growth hormones; vaccines for human use; viral vaccines

1 Biological, biochemical and chemical preparations for use in industry, science and for scientific purposes other than for medical or veterinary use; biological preparations for use in cell cultures other than for medical or veterinary use; stem cells for research purposes; stem cells for science, for scientific purposes; biological microorganisms other than for medical or veterinary use; cultures of microorganisms other than for medical or veterinary use ; cultures of microorganisms and cell media cultures other than for medical or veterinary use; biological tissue from different organs, namely from rodent, primate and human biopsy and cell media cultures, other than for medical or veterinary use; cultures of microorganisms for industrial use, other than for medical or veterinary use; cell culture media for laboratory use; cell culture media for use in non-medical research laboratories and in the biotechnology industry; cell growth media for cell culture for use in scientific research; solutions for non-medical scientific use for storing and preserving human organs; chemical compositions for scientific and industrial use for the preparation of culture media; biochemicals for in-vitro and in-vivo scientific use; chemical for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; chemical laboratory preparations for scientific purposes, other than for medical or veterinary use ; preservatives for the viability of micro-organisms in cultures for pharmaceutical industrial use; biological preparations other than for medical and veterinary use; bacterial preparations for scientific and industrial use; chemical preparations for analyses in laboratories, other than for medical or veterinary use; chemical preparations for pathological examinations, other than for medical and veterinary use; chemical preparations, biochemical preparations, reagents, chemical reagents and diagnostic preparations for scientific or research use other than for medical or veterinary use; diagnostic reagents for in-vitro use other than for medical use, in vivo for scientific use, in-vitro use for biochemistry, clinical chemistry and microbiology; reagents for in-vitro use in laboratories other than for medical or veterinary use; cell culture reagents for scientific use and for research; reagents for chemical and microbiological analysis other than for medical or veterinary use; test reagents for scientific or industrial use other than medical use; chemical reagents for use in scientific field, for molecular biology and for biotechnology other than for medical or veterinary use; chemical preparations used for analysis, reagents for analytical tests and diagnostic tests for biological treatment other than for medical or veterinary use

42 Scientific, technological and biotechnological services, namely analysis, tests, design, advices and studies in the field of neurosciences, cancer, genetics, epigenetics, microbiology and viruses; pharmaceutical product evaluation in the nature of conducting scientific studies and tests on pharmaceutical products; scientific laboratory services; biological and medical research laboratory services; chemical research laboratory services; pharmaceutical research and development services in the field of cytology, chemistry, gene expression systems, engineering, biotechnology, physics and medical field; pharmaceutical research and development services in the field of vaccines; pharmaceutical product development services; scientific research services for medical purposes concerning all pathologies; biochemical research services; drug discovery services; DNA screening services for scientific research; biological cloning services; biochemical engineering; chemical engineering; genetic engineering services in the nature of neurosciences, cancer, genetics, epigenetics, microbiology and viruses; microbiological testing services in the nature of fluids analysis, blood analysis, cerebrospinal fluid analysis, urine analysis; scientific research services with respect to the isolation and cultivation of human cells, and of tissues; biotechnology product testing, technical product testing and pharmaceutical product testing services; product testing in the nature of services for assessing the efficiency of pharmaceutical products and industrial chemicals; blood analysis services for scientific research purposes; providing information relating to scientific research; consulting services in the fields of neurosciences, cancer, genetic, epigenetics, microbiology, viruses and vaccine; advisory services and technical consulting in the fields of neurosciences, cancer, genetic, epigenetics, microbiology, viruses and vaccine; advisory services with respect to gene therapy research; advisory services with respect to research and development in the field of therapeutics and biotechnology; advisory services in engineering and with respect to biochemistry; advisory services with respect to scientific laboratory services; consulting services in the field of pharmaceutical research and development; consulting services in the field of information technology for the pharmaceutical and health industries; consulting services in the field of biology and pharmaceutical research and development; medical, biomedical, pharmaceutical and pharmacological research relating to services; chemical research and analysis services; laboratory research services relating to pharmaceutical products; laboratory research in the field of biotechnology and chemistry; biological research; pharmaceutical research services; technology research in the field of neurosciences, cancer, genetic, epigenetics, microbiology, viruses and vaccine; biotechnology research; research in the field of neurosciences, cancer, genetic, epigenetics, microbiology, viruses and vaccine; research in the field of chemistry; research in the field of biochemistry; scientific research in the field of genetics scientific; research in the field of molecular science, genetic engineering, gene therapy, pharmaceuticals and pharmacogenetics; scientific research for medical purposes concerning all pathologies; biological and medical research; clinical research in the field of neurosciences, cancer, genetic, epigenetics, microbiology, viruses and vaccine; biological and biochemical research and analysis; research and development of products, new products, vaccines and medicines; scientific, biotechnological, biochemical research and development for the pharmaceutical industry; research and development in the field of diagnostic preparations; development of pharmaceutical preparations, products and medicines; scientific research in the field of cell culture; scientific research in the field of stem cells; research and development in the field of stem cells; research services in the field of neurosciences, cancer, genetic, epigenetics, microbiology and viruses, namely, biological sample preparations for research purposes, for testing and analysis in research laboratories; tissue engineering; cultivation and engineering of cells and tissues for scientific and research purposes, for others; analysis in the field of molecular biology and technology engineering; medical research in the nature of analyses on human tissues and human serums; scientific research in the field of neurosciences, cancer, genetic, epigenetics, microbiology, viruses and vaccine, conducted using databases; medical research conducted using databases; technology research in the field of neurosciences, cancer, genetic, epigenetics, microbiology and viruses provided by engineers testing new products, chemical products, engineering, toxicity for research purposes; genetic testing on laboratory animals for research purposes; design and testing in the framework of new product development; designing and developing engineering products; conducting engineering studies in the nature of preclinical molecules screening, clinical trials, vaccine, therapeutics, genetics in the field of biochemistry and biotechnology; preparation of reports with respect to biotechnology; providing information relating to medical and scientific research information in the field of pharmaceuticals, clinical trials and scientific technology; providing information relating to scientific research and information services with respect to technological research; providing information relating to scientific research in the field of biochemistry and biotechnology

The mark consists of the following: a stylized brain in light blue overlapped by stylized gears and microorganisms in light blue, dark blue and orange shapes with the words "RESEARCH" in dark blue underneath and "PIECES" in smaller stylized orange text under the word "RESEARCH".
The color(s) light blue, dark blue and orange is/are claimed as a feature of the mark.
"RESEARCH"

Trademark Events

Feb 27, 2023

New Application Office Supplied Data Entered

Mar 3, 2023

Application Filing Receipt Mailed

Feb 24, 2023

Sn Assigned For Sect 66a Appl From Ib

Sep 9, 2023

Assigned To Examiner

Nov 29, 2023

Refusal Processed By Mpu

Mar 26, 2023

New Representative At Ib Received

Nov 27, 2023

Non-Final Action Written

Nov 28, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Nov 29, 2023

Non-Final Action Mailed - Refusal Sent To Ib

May 3, 2024

Correspondence Received In Law Office

May 3, 2024

Teas/Email Correspondence Entered

May 3, 2024

Teas Response To Office Action Received

Dec 19, 2023

Refusal Processed By Ib